DNASE1 and necrotizing enterocolitis: Furthermore, systemic DNase1 treatment dramatically lowered NEC severity and mortality, and the outcomes were confirmed in human subjects [103], Therefore, DNase1 is considered as a therapeutic option for NEC neonates.